Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Elanco completed a $120 million, 25,000-square-foot expansion of its Elwood, Kansas manufacturing site, increasing monoclonal antibody (mAb) production capacity by over four times.
Volition's Nu.Q® NETs H3.1 biomarker validated as an independent predictor of 28-day mortality and need for renal replacement therapy (RRT) in sepsis patients.
VR Resources intersected 317 meters at 0.77% CuEq starting at surface, above 419 meters of 0.48% CuEq in an 881-meter drill hole at New Boston Porphyry-Skarn project in Nevada.
Palladyne AI and NORDA Dynamics announced a collaboration to integrate SwarmOS™ with NORDA’s Underdog Autonomy Module for enhanced autonomous drone swarm operations.
First patient dosed in TROPION-Urothelial04 Phase 3 trial evaluating Datroway® (datopotamab deruxtecan) plus rilvegostomig or Datroway monotherapy versus current standard of care in high-risk muscle invasive urothelial cancer (MIUC).
